Novavax Inc. Stock Advances 15.0%, Outperforms Competitors

Dow Jones
May 20, 2025

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Novavax Inc. climbed 15.0% to $7.74 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index remaining mostly unchanged at 19,215.46 and the Dow Jones Industrial Average rising 0.3% to 42,792.07.

This was the stock's third consecutive day of gains.

Novavax Inc. closed 67.6% below its 52-week high of $23.86, which the company reached on June 6th.

The stock outperformed some of its competitors, as Johnson & Johnson rose 0.8% to $152.49, Pfizer Inc. rose 0.7% to $23.00, and Merck & Co. Inc. rose 1.54% to $77.23.

Trading volume totaled 83.7 million, compared to the 50-day average of 6.9 million.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

May 19, 2025 16:32 ET (20:32 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10